Literature DB >> 9846037

Mania-like syndrome in a patient with chronic schizophrenia during olanzapine treatment.

P Pozo, A G Alcántara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9846037      PMCID： PMC1188960     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  12 in total

1.  Re: Hypomania associated with risperidone.

Authors:  F O'Croinin; T Zibin; L Holt
Journal:  Can J Psychiatry       Date:  1995-02       Impact factor: 4.356

2.  Effective treatment of mania with olanzapine: 2 case reports.

Authors:  A V Ravindran; B W Jones; K al-Zaid; Y D Lapierre
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

3.  Mania associated with olanzapine.

Authors:  J A London
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1998-02       Impact factor: 8.829

4.  Treatment of psychotic depression.

Authors:  C Debattista; H B Solvason; J Belanoff; A F Schatzberg
Journal:  Am J Psychiatry       Date:  1997-11       Impact factor: 18.112

5.  Manic symptoms associated with initiation of risperidone.

Authors:  B J Schnierow; D A Graeber
Journal:  Am J Psychiatry       Date:  1996-09       Impact factor: 18.112

6.  Risperidone treatment of bipolar disorder.

Authors:  R McIntyre; L T Young; G Hasey; I Patelis-Siotis; B D Jones
Journal:  Can J Psychiatry       Date:  1997-02       Impact factor: 4.356

7.  Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Authors:  G D Tollefson; T M Sanger; Y Lu; M E Thieme
Journal:  Arch Gen Psychiatry       Date:  1998-03

8.  Risperidone in the treatment of mania.

Authors:  M Tohen; C A Zarate; F Centorrino; J I Hegarty; M Froeschl; S B Zarate
Journal:  J Clin Psychiatry       Date:  1996-06       Impact factor: 4.384

9.  Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Authors:  F P Bymaster; D O Calligaro; J F Falcone; R D Marsh; N A Moore; N C Tye; P Seeman; D T Wong
Journal:  Neuropsychopharmacology       Date:  1996-02       Impact factor: 7.853

Review 10.  Serotonin-dopamine interaction and its relevance to schizophrenia.

Authors:  S Kapur; G Remington
Journal:  Am J Psychiatry       Date:  1996-04       Impact factor: 18.112
View more
  4 in total

Review 1.  Olanzapine: an updated review of its use in the management of schizophrenia.

Authors:  N Bhana; R H Foster; R Olney; G L Plosker
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Rapid cycling bipolar disease: new concepts and treatments.

Authors:  S L Dubovsky
Journal:  Curr Psychiatry Rep       Date:  2001-12       Impact factor: 5.285

Review 3.  Atypical antipsychotics and mood stabilization in bipolar disorder.

Authors:  Paolo Brambilla; Francesco Barale; Jair C Soares
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

Review 4.  Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights.

Authors:  Salvatore Gentile
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.